Human Immunome Project is now accepting applications for the 2023 Michelson Prizes: Next Generation Grants.
The 2023 Michelson Prizes are looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding their limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. Reviewers will be looking for research that is highly innovative and impactful, with the potential to be applied across many diseases.
The Michelson Prizes are intended to support individuals early in their careers who possess novel ideas with applications across diseases and who have significant potential to execute these ideas to affect transformative change in their respective fields. Research that incorporates multiplexed and nontraditional approaches from outside the fields of immunology and vaccinology and demonstrates a high degree of novelty and creative thinking is encouraged. The successful applicants will clearly articulate a vision that challenges current dogma and demonstrates an ability to look beyond convention to make a lasting impact on vaccine and immunotherapy research.
The Michelson Prizes seek to draw young investigators from a wide range of disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, microbiome, tropical medicine, environmental health, etc.
- The Michelson Prizes are focused on research in the fields of immunology, vaccine and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc.,
- The Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
- Applicants must be 35 or younger at the time of submission.
- Early career independent investigators, postdoctoral fellows, clinical fellows (including residents and interns), and other researchers currently in training positions are eligible for these awards.
- Applicants must be employed by, or affiliated with, an eligible organization (e.g., academia, biotechnology companies, foundations, government and non-governmental organizations, and research institutes).
- All applications for the Michelson Prizes must be submitted electronically by the application deadline. Paper applications will not be accepted.
- Researchers from around the world are eligible to apply for the Michelson Prizes. The Michelson Prizes are committed to fostering diversity, equity, and inclusion in science – as such, they strongly encourage applications from women, people of color, scientist from outside the United States, and other underrepresented groups.
- Short-listed applicants notified: September 2023
- Supplementary information due: October 2023 (exact date to be communicated)
- Notice of award: December 2023
- Grant cycle: January 1 — December 31, 2024
For more information, visit Human Immunome Project.